BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced the pricing of its initial public offering of 20,500,000 shares of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE